Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.12 USD | -0.11% | +6.17% | +40.31% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.31% | 6.63B | |
+44.99% | 56.65B | |
-7.24% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.08% | 26.75B | |
-21.49% | 19.03B | |
+1.05% | 12.28B | |
+23.54% | 12.26B | |
+27.10% | 12.04B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Revolution Medicines, EQRx Stockholders Approve Merger